Curis Inc (CRIS) stock
CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3092% below fair value
$0.54+0.11 (+24.32%)
Close on Nov 17, 2026Market cap $1.13MP/E –Yield –
Curis price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Curis's price to book ratio was 0.2× on Nov 11, 2026, against 6.5× a year earlier. Over the last 5 years it ranged from 0.2× to 49.5×, with a median of 2.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.2× | −3.2 |
| 2024 | Jul 31, 2024 | 3.4× | +0.9 |
| 2023 | Dec 29, 2023 | 2.5× | +1.6 |
| 2022 | Dec 30, 2022 | 1.0× | −3.3 |
| 2021 | Dec 31, 2021 | 4.2× | −45.3 |
| 2019 | Jan 31, 2019 | 49.5× | +20.3 |
| 2018 | Dec 31, 2018 | 29.2× | +25.4 |
| 2017 | Dec 29, 2017 | 3.8× | −7.6 |
| 2016 | Dec 30, 2016 | 11.4× | +6.5 |
| 2015 | Dec 31, 2015 | 4.9× | +1.2 |
| 2014 | Dec 31, 2014 | 3.7× | −2.0 |
| 2013 | Dec 31, 2013 | 5.7× | −0.3 |
| 2012 | Dec 31, 2012 | 6.0× | −5.1 |
| 2011 | Dec 30, 2011 | 11.1× | – |
See a number that looks wrong?